Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer.

for
Early Breast Cancer
Location: Dobbs Ferry NY, Los Angeles CA, Morgantown WV,
Sponsor: University College, London

Sex: Female

Age: 0+

Code: NCT01792726

Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Boston MA, Providence RI, Norwalk CT, New York NY,
Sponsor: Fore Biotherapeutics

Sex: All

Age: 8+

Code: NCT05503797

Phase 2, Recruiting

FES BPET-DBT in Newly Diagnosed Breast Cancer

for
Breast Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: Female

Age: 18+

Code: NCT05659797

Early Phase 1, Recruiting

SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization

for
Prostate Cancer, Advanced Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18 - 70+

Code: NCT06389097

Recruiting

Multi-Cancer Early Detection (MCED) of Firefighters

for
Cancer
Location: Scottsdale AZ
Sponsor: Vincere Cancer Center

Sex: All

Age: 18+

Code: NCT05780957

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings

for
Breast Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Female

Age: 18+

Code: NCT06268405

Recruiting

Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training

for
Pediatric Cancer
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 7 - 17

Code: NCT05000905

Recruiting

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

for
Cancer, Liver Cirrhosis, Chronic Hepatitis, Hepatitis B,
Location: Memphis TN, Fridley MN, Minneapolis MN, Coon Rapids MN,
Sponsor: Helio Genomics

Sex: All

Age: 18+

Code: NCT05181826

Recruiting

Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen

for
Breast Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05056857

Recruiting

A Pilot Study of Genetic Testing Uptake Through Enhanced Oncology Nurse-Led Intervention

for
Solid Tumor, Adult
Location: Chico CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT06436157

Recruiting

Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Columbus OH
Sponsor: Margaret Gatti-Mays

Sex: All

Age: 18+

Code: NCT06026657

Phase 1, Phase 2, Recruiting

Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A

for
Solid Tumors
Location: San Antonio TX
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT03950297

Phase 1, Recruiting

A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

for
Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL)
Location: Huntersville NC
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT05569057

Phase 1, Recruiting

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

for
Neoplasms
Location: The Bronx NY, New York NY, East Brunswick NJ,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06150157

Phase 1, Recruiting

HER2-positive Breast Cancer Registry

for
HER2 + Breast Cancer
Location: Westwood KS
Sponsor: Priyanka Sharma

Sex: All

Age: 18+

Code: NCT06603597

Recruiting

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

for
Cancer, Breast, Cancer, Lung, Cancer of Pancreas,
Location: Manhasset NY, Orlando FL, Cerritos CA
Sponsor: Coherent Biopharma (Hefei) Co., Ltd.

Sex: All

Age: 18+

Code: NCT05830097

Phase 1, Phase 2, Recruiting

Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders

for
Skin Diseases
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 0+

Code: NCT05649098

Early Phase 1, Recruiting

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions

for
Brain Metastases, Adult, Neurocognitive Function, Cancer,
Location: San Diego CA
Sponsor: Jona Hattangadi-Gluth

Sex: All

Age: 18+

Code: NCT04343157

Phase 2, Recruiting

Evaluation of Grief Therapy Approaches for Bereaved Parents

for
Grief, Bereavement, Cancer
Location: New York NY, Philadelphia PA, Memphis TN, Stanford CA
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT05142605

Recruiting

Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue

for
Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT06127797

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial